You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Factor XI

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteer Trial in Leeds (REGN7508 (IV), REGN7508 (SC), Matching Placebo (IV))

Recruiting
  • Healthy Volunteer
  • REGN7508 (IV)
  • +3 more
  • Leeds, United Kingdom
    Labcorp Clinical Research Unit
Jan 30, 2023

Venous Thromboembolism Trial (REGN9933, Enoxaparin, Apixiban)

Not yet recruiting
  • Venous Thromboembolism
  • (no location specified)
Nov 8, 2022

Healthy Volunteers Trial in Edegem (REGN9933, Placebo)

Recruiting
  • Healthy Volunteers
  • Edegem, Antwerp, Belgium
    Regeneron Study Site
Jul 1, 2022

Healthy Participants Trial in Toronto (IONIS FXI-LRx, Placebo)

Completed
  • Healthy Participants
  • IONIS FXI-LRx
  • Placebo
  • Toronto, Ontario, Canada
    BioPharma Services Inc.
Jan 13, 2022

End-stage Renal Disease (ESRD) Trial in Santiago De Compostela, Alcalá De Henares (ISIS 416858, Placebo)

Completed
Has Results
  • End-stage Renal Disease (ESRD)
  • ISIS 416858
  • Placebo
  • Santiago De Compostela, A Coruna, Spain
  • +1 more
Dec 22, 2022

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency Trial in China (SS109)

Recruiting
  • Hemophilia A With Inhibitor
  • +2 more
  • SS109
  • Hefei, Anhui, China
  • +9 more
Jan 12, 2023

Lymphoma, Malignant Solid Tumor, Plasma Cell Myeloma Trial in Portland (Xisomab 3G3)

Recruiting
  • Lymphoma
  • +2 more
  • Xisomab 3G3
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 28, 2022

Male, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in China (SS109)

Not yet recruiting
  • Male
  • +3 more
  • Hefei, China
  • +8 more
Aug 24, 2023

Breast Cancer Stage II Trial in Xi'an (Anlotinib)

Recruiting
  • Breast Cancer Stage II
  • Xi'an, Shannxi Province, China
    Xijing Hospital Affiliated to Air Force Military Medical Univers
Sep 25, 2022

End Stage Renal Disease Requiring Hemodialysis Trial in Worldwide (BAY2976217, Placebo)

Completed
  • End Stage Renal Disease Requiring Hemodialysis
  • Clovis, California
  • +68 more
Jan 20, 2023

NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Kogarah, Australia
  • +29 more
Oct 20, 2022

NSCLC Trial in China (Osimertinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Beijing, China
  • +3 more
Sep 15, 2022

Breast Cancer Trial in China (TQB2102 for injection)

Not yet recruiting
  • Breast Cancer
  • TQB2102 for injection
  • Hefei, Anhui, China
  • +20 more
Nov 1, 2023

NSCLC Trial (Furmonertinib, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Changchun, China
  • +25 more
Aug 26, 2022

Osimertinib for Patients With Non-Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • EGFR Exon20 Insertion Mutations
  • Baoding, China
  • +23 more
Aug 23, 2022

NSCLC Trial in China (DZD9008, Pemetrexed+carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Beijing, China
  • +40 more
Dec 20, 2022

End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Trial in Worldwide (MK-2060, Placebo)

Recruiting
  • End-Stage Renal Disease
  • +2 more
  • Huntsville, Alabama
  • +95 more
Aug 4, 2022

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide (gilteritinib, LoDAC (Low Dose

Active, not recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Beijing, China
  • +47 more
Aug 17, 2022

Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,

Recruiting
  • Locally Advanced (Inoperable) or Metastatic Breast Cancer
  • Los Angeles, California
  • +76 more
Nov 25, 2022

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer Trial in Worldwide (AZD9291 80

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
  • AZD9291 80 mg/40 mg + placebo
  • +5 more
  • Anaheim, California
  • +168 more
Nov 29, 2022

Menstrual Bleeding, Heavy Trial in Portland (Sample Collection and Endometrial Biopsy)

Not yet recruiting
  • Menstrual Bleeding, Heavy
  • Sample Collection and Endometrial Biopsy
  • Portland, Oregon
    OHSU
May 8, 2023

Intracerebral Hemorrhage Trial in Gent, Mons, Kortrijk (Ir-CPI)

Recruiting
  • Intracerebral Hemorrhage
  • Gent, East Flanders, Belgium
  • +2 more
Aug 2, 2023

An Investigator-initiated Linked Study to OCEANIC-AF

Recruiting
  • Atrial Fibrillation
  • Thrombotic assessment
  • Liverpool, United Kingdom
  • +1 more
Nov 5, 2023

Coagulation, Inflammation and Vessels in Chronic Liver Disease

Not yet recruiting
  • Chronic Liver Diseases
  • Coagulation
  • biomarker assay
  • (no location specified)
May 9, 2023

NSCLC Trial in Worldwide (Osimertinib, Pemetrexed/Carboplatin, Pemetrexed/Cisplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Bellflower, California
  • +154 more
Dec 23, 2022